|
Index of reports
> Life Threatening Events (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Omniscan (Gadodiamide) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Omniscan side effects in 56 year old male
Reported by a consumer/non-health professional from United States on 2012-04-27
Patient: 56 year old male
Reactions: Aphagia, Abasia, Skin Induration, Erythema, Walking AID User, Finger Deformity, Malaise, Joint Swelling, Skin Discolouration, Arthralgia, Oedema Peripheral, Pharyngitis Streptococcal, Urinary Retention, Infection
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Indication: Hepatic Cirrhosis
Omniscan
Indication: Hepatic Cirrhosis
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2009-02-24
End date: 2009-02-24
Omniscan
Dosage: 20 mg, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2009-02-24
End date: 2009-02-24
Other drugs received by patient: Sodium Chloride; Sodium Chloride
Possible Omniscan side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-30
Patient: male, weighing 88.5 kg (194.6 pounds)
Reactions: Myalgia, Pain, Coma, Pyrexia, Unevaluable Event, Erythema
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Omniscan
Dosage: 20.0 intravenous
Indication: Imaging Procedure
Start date: 2009-02-24
Sodium Chloride 0.9%
Dosage: 40.0 ml intravenous
Indication: Imaging Procedure
Start date: 2009-02-24
Possible Omniscan side effects in male
Reported by a physician from Japan on 2012-03-28
Patient: male
Reactions: Morphoea, Joint Contracture, Pain, Joint Range of Motion Decreased, Skin Discolouration, Feeling Hot, Oedema Peripheral, Arteriovenous Fistula Site Complication, Pain in Extremity, Muscular Weakness, Skin Disorder, Calcinosis, Nephrogenic Systemic Fibrosis, Skin Induration, Gait Disturbance, Sclerema
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Omniscan
Indication: Renal Transplant
Start date: 2000-07-18
End date: 2000-07-18
Omniscan
Indication: Anastomotic Stenosis
Other drugs received by patient: Multiple Unspecified Drugs; Magnevist
|
